Stock NHI NATIONAL HEALTH INVESTORS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings National Health Investors, Inc.

Equities

NHI

US63633D1046

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
62.89 USD +0.45% Intraday chart for National Health Investors, Inc. +2.23% +12.61%
Apr. 18 Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting CI
Mar. 18 Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The firm trades with high earnings multiples: 22.14 times its 2024 earnings per share.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+12.61% 2.73B
C-
WELLTOWER INC. Stock Welltower Inc.
+4.62% 55.76B
A-
VENTAS, INC. Stock Ventas, Inc.
-11.72% 17.72B
A-
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-5.05% 13.23B
A
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+1.40% 7.68B
B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-16.54% 5.39B
B-
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+8.62% 3.28B
C-
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-2.31% 3.23B
C+
AEDIFICA SA Stock Aedifica SA
-5.42% 3.06B
B+
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-8.15% 2.73B
C
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NHI Stock
  4. Ratings National Health Investors, Inc.